Aurora Cannabis aims 64% stock rise with strong cash position and international growth.

Aurora Cannabis has refocused as a cannabis-centric company, improving its international revenue and margins while spinning off its Bevo division. The company now holds net cash of C$46.7 million after equity sales, with its enterprise value trading at a low multiple of projected FY27 adjusted EBITDA. Analyst Alan Brochstein projects a 64% upside to US$5.58 within a year, based on a 6x FY28 EBITDA multiple, noting the stock trades below tangible book value. Risks include earnings volatility, regulatory challenges, and potential missteps in U.S. market entry.